Evaluation of novel methotrexate nanoparticles for anticancer action
Keywords:
Invitro, Invivo anticancer activities, Methotrexate nanoparticles and toxicity studiesAbstract
Methotrexate-chitosan nanoparticles (MTX-NP) were prepared by method of Tripolyphosphate (TPP) ionic cross- linking. Influence of preparation conditions on physicochemical properties were analyzed by DLS, SEM & FTIR. In- vitro drug release properties were investigated by UV–VIS spectroscopy. In vitro anti-cancerous activities (MTT assay, apoptosis assay, cell cycle arrest & ROS indices) of MTX/MTX-NP were evaluated on HT-1080 & MCF-7 cells. Comparative (MTX/MTX-NP) in vivo pharmacokinetic & Acute/sub acute toxicity studies carried out on Wistar rats. In conclusion, prepared MTX-NP has played significant role in increasing in vitro-anti cancer efficacy, in vivo pharmacokinetic profiles & as well helps in reducing toxic effect.
Downloads
Published
Issue
Section
License
Rights and reuse terms depend on the individual article record. Articles accepted on or after 8 September 2026 are licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), provided appropriate credit is given, a link to the licence is supplied and changes are indicated. Earlier content remains governed by the rights and licence notice applicable to that article and is not retrospectively relicensed by this policy. Third-party material identified under a different notice is excluded from the journal licence.

